Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[DCC gene and leukemia].

K Miyake1, K Inokuchi

  • 1Third Department of Internal Medicine, Nippon Medical School.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|June 1, 1992
PubMed
Summary
This summary is machine-generated.

The deleted in colorectal carcinomas (DCC) gene, a potential tumor suppressor, shows reduced or absent expression in colorectal cancer and some leukemias. This suggests DCC may play a role in the development of leukemia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TdT-Positive, SmIg-Negative B Precursor Cell Leukemia with Burkitt Morphology: A Case Report.

Leukemia & lymphoma·2016
Same author

Complex molecular genetic abnormalities involving three or more genetic mutations are important prognostic factors for acute myeloid leukemia.

Leukemia·2015
Same author

Inhibition of S100A6 induces GVL effects in MLL/AF4-positive ALL in human PBMC-SCID mice.

Bone marrow transplantation·2014
Same author

Mutations of the epigenetics-modifying gene (DNMT3a, TET2, IDH1/2) at diagnosis may induce FLT3-ITD at relapse in de novo acute myeloid leukemia.

Leukemia·2012
Same author

Resistance of MLL-AFF1-positive acute lymphoblastic leukemia to tumor necrosis factor-alpha is mediated by S100A6 upregulation.

Blood cancer journal·2012
Same author

Importance of c-kit mutation detection method sensitivity in prognostic analyses of t(8;21)(q22;q22) acute myeloid leukemia.

Leukemia·2011
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Area of Science:

  • Molecular biology
  • Genetics
  • Oncology

Context:

  • The deleted in colorectal carcinomas (DCC) gene, identified in 1990, is located at chromosome band 18q21.
  • DCC encodes a protein similar to neural cell adhesion molecules and cell surface glycoproteins.
  • DCC gene expression is significantly reduced or absent in 88% of colorectal carcinoma cases.

Purpose:

  • To investigate the expression of the DCC gene in leukemias.
  • To determine if DCC gene alterations are associated with leukemogenesis.

Summary:

  • Reverse transcriptase-polymerase chain reaction (RT-PCR) was used to analyze DCC gene expression.
  • Reduced or absent DCC gene expression was observed in some leukemia samples.
  • These findings indicate a potential role for the DCC gene in the development of leukemia.

Related Experiment Videos

Impact:

  • Highlights the potential involvement of the DCC gene in leukemogenesis.
  • Suggests DCC as a possible target for future research in leukemia.
  • Expands understanding of tumor suppressor gene functions beyond colorectal cancer.